Animal studies further confirmed caffeine's anti-obesity effects through modulation of hepatic AMPKα-liver X receptor alpha (LXRα)/sterol regulatory element-binding protein 1c (SREBP-1c) signaling pathway (68). The gene discussed is NR1H3; the disease is obesity disorder.